However, there hasnt been a large focus on stomach paralysis, and Novo Nordisk has not included warnings about gastroparesis in the drug information as of February 2024
[25:06] Its very interesting because its one of those modulators, and thats the beautiful aspect of natural substances is they have intelligent mechanisms meaning when theres too much inflammation, they will down-regulate it
We further examined whether acute administration of tirzepatide (GLP-1/GIP) and retatrutide (GLP-1/GIP/glucagon), which is currently undergoing testing in clinical trials, would recapitulate or enhance the effects observed with semaglutide
How to Use: 1
Unfortunately, as mentioned earlier, weight regain is common after discontinuation
Like any medication, there could be potential side effects, but they are typically mild